E. DEMIRCI Et Al. , "177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44, 2017
DEMIRCI, E. Et Al. 2017. 177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44 .
DEMIRCI, E., AKYEL, R., Şahin, O. A., Ocak, M. T., Aygün, A., Pehlivanoglu, H., ... Karayel, E.(2017). 177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44.
DEMIRCI, E. Et Al. "177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival," EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44, 2017
DEMIRCI, E. Et Al. "177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44, 2017
DEMIRCI, E. Et Al. (2017) . "177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival." EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , vol.44.
@article{article, author={E. DEMIRCI Et Al. }, title={177Lu-PSMA-617 Treatment of Metastatic Castration-Resistant Prostate Cancer: Efficacy and Survival}, journal={EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING}, year=2017}